No additional weight-loss reported from a lifestyle programme for people with psychosis

People with schizophrenia are twice as likely to be overweight as the general population, as medication side effects frequently include weight gain. This NIHR-funded study with over 400 participants in 10 areas across England is the largest UK randomised trial to date. It shows that this hard-to-reach group can be recruited and retained in structured self-management programmes delivered by trained facilitators. However, it was neither clinically effective nor cost-effective. Alternative, affordable approaches are much needed.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news